The average age for the onset of breast cancer in PALB2 c.1592delT carriers is 53.1 years, which is somewhat higher than in Finnish BRCA1/BRCA2 mutation carriers (45.2/47.4 years), but considerably lower than in sporadic patients (58.0 years) [14]. This evidence concerns the gene PALB2 and breast cancer.